InvestorsObserver
×
News Home

Should You Accumulate Biotricity Inc (BTCY) in Medical Devices Industry?

Friday, October 27, 2023 09:59 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Accumulate Biotricity Inc (BTCY) in Medical Devices Industry?

The 67 rating InvestorsObserver gives to Biotricity Inc (BTCY) stock puts it near the top of the Medical Devices industry. In addition to scoring higher than 95 percent of stocks in the Medical Devices industry, BTCY’s 67 overall rating means the stock scores better than 67 percent of all stocks.

Overall Score - 67
BTCY has an Overall Score of 67. Find out what this means to you and get the rest of the rankings on BTCY!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 67 means the stock is more attractive than 67 percent of stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Biotricity Inc Stock Today?

Biotricity Inc (BTCY) stock is down -26.7% while the S&P 500 has risen 0.15% as of 9:46 AM on Friday, Oct 27. BTCY is down -$0.51 from the previous closing price of $1.91 on volume of 72,289 shares. Over the past year the S&P 500 is up 8.83% while BTCY is down -81.18%. BTCY lost -$2.08 per share the over the last 12 months. Click Here to get the full Stock Report for Biotricity Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App